Chemical Structure : Daratumumab
CAS No.: 945721-28-8
货号: PC-Ab1043Not For Human Use, Lab Use Only.
Daratumumab is a human monoclonal antibody that targets CD38, depletes plasma cells and is approved for the treatment of multiple myeloma. Daratumumab inhibits the growth of CD38 expressing tumor cells and induces apoptosis (cell death) directly through mediated cross linking and by immune mediated tumor cell lysis through complement dependent cytotoxicity, antibody cell mediated cytotoxicity, and antibody dependent cellular phagocytosis..
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
1 mg | ¥3580 | In stock | |
5 mg | ¥7580 | In stock | |
10 mg | ¥12800 | In stock | |
100 mg | Get quote |
大包装,大折扣!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
Daratumumab is a human monoclonal antibody that targets CD38, depletes plasma cells and is approved for the treatment of multiple myeloma. Daratumumab inhibits the growth of CD38 expressing tumor cells and induces apoptosis (cell death) directly through mediated cross linking and by immune mediated tumor cell lysis through complement dependent cytotoxicity, antibody cell mediated cytotoxicity, and antibody dependent cellular phagocytosis.
分子量 | ||
分子式 | Human IgG1-Kappa | |
外观性状 | Solid | |
储存条件 |
|
|
Solubility |
PBS, pH 7.0 Contains no stabilizers or preservatives |
|
Chemical Name/SMILES |
Daratumumab; Darzalex; 945721-28-8; anti-CD38; CD38 Antigen; Cluster Of Differentiation 38 |
1. 1, Larysa Sanchez et al. J Hematol Oncol. 2016; 9: 51. 2, Palumbo A, et al. N Engl J Med. 2016 Aug 25;375(8):754-66. 3, Dimopoulos MA, et al. N Engl J Med. 2016 Oct 6;375(14):1319-1331. 4, de Weers M, et al. J Immunol. 2011 Feb 1;186(3):1840-8. 5, Nijhof IS, et al. Haematologica. 2015 Feb;100(2):263-8.
备案号:沪ICP备16042516号-1 Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright